Literature DB >> 8825164

Evaluation of synthetic serum substitute versus serum as protein supplementation for mouse and human embryo culture.

K E Tucker1, B S Hurst, S Guadagnoli, C Dymecki, B Mendelsberg, C A Awoniyi, W D Schlaff.   

Abstract

PURPOSE: Our purpose was to determine the effect of Synthetic Serum Substitute (SSS) versus serum supplementation on fertilization rates and subsequent development of embryos from patients undergoing IVF. PROCEDURE: Experiment I compared the effects of SSS to human serum on mouse embryo development. Two hundred one-cell B6D2F1 mouse embryos were cultured in 100-microliter droplets of human tubal fluid (HTF) containing either (1) no protein (control; n = 37), (2) 15% serum from women with tubal infertility (n = 44), (3) 15% serum from women with endometriosis (n = 49), (4) 15% fertile donor serum (n = 33), or (5) 15% SSS (n = 37). Experiment II compared the effects of SSS to human serum on the development of embryos from patients undergoing IVF. Thirty-three women were included in this study. A total of 371 oocytes was cultured in HTF containing either (1) maternal or donor serum (n = 140) or (2) 15% SSS (n = 231). Embryo development was evaluated 48 hr after fertilization.
RESULTS: In Experiment I, the rate of blastocyst development was evaluated at 48, 72, and 96 hr of culture. Sixty-four and nine-tenths percent of embryos cultured in SSS were morulae at 48 hr of culture (versus 5.4, 0, 8.2, and 6.1 in Groups 1, 2, 3, and 4, respectively). By 72 hr, 29.7% of these embryos had developed into blastocysts (versus 0, 0, 8.2, and 3.0, for Groups 1, 2, 3, and 4, respectively). This percentage increased to a total of 83.7 after 96 hr (versus 27.0, 20.4, 38.8, and 39.4 for Groups 1, 2, 3, and 4, respectively). Forty-three and two-tenths percent of the blastocysts cultured in SSS had hatched from their zonae by 96 hr. With the exception of Group 5, which had a rate of 9.1%, embryo hatching was not observed in any of the groups at the termination of culture (96 hr). In Experiment II there were no differences in cell stage or quality of human embryos cultured in SSS or serum, but fertilization rates tended to be better (P = 0.07) for oocytes inseminated in media containing SSS (70.0%, vs 55.0% for serum).
CONCLUSIONS: SSS appears to be a superior protein source for mouse embryo growth and is as good as serum from fertile donors in promoting in vitro human embryo development.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8825164     DOI: 10.1007/bf02068866

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  10 in total

1.  Effect of serum from patients with minimal to mild endometriosis on mouse embryo development in vitro.

Authors:  M D Damewood; J S Hesla; W D Schlaff; M Hubbard; J D Gearhart; J A Rock
Journal:  Fertil Steril       Date:  1990-11       Impact factor: 7.329

2.  The effect of protein supplementation on single-cell mouse embryos in vitro.

Authors:  T Ogawa; R P Marrs
Journal:  Fertil Steril       Date:  1987-01       Impact factor: 7.329

3.  Serum supplement in human in vitro fertilization and embryo development.

Authors:  P C Leung; M J Gronow; G N Kellow; A Lopata; A L Speirs; J C McBain; Y P du Plessis; I Johnston
Journal:  Fertil Steril       Date:  1984-01       Impact factor: 7.329

4.  Evaluation of a synthetic serum substitute to replace fetal cord serum for human oocyte fertilization and embryo growth in vitro.

Authors:  I Psalti; E Loumaye; M Pensis; S Depreester; K Thomas
Journal:  Fertil Steril       Date:  1989-11       Impact factor: 7.329

5.  Serum from patients with threatened abortion. Effect on in vitro development of mouse embryos.

Authors:  A Abu-Musa; K Takahashi; S Okada; R Sakoda; M Kitao
Journal:  J Reprod Med       Date:  1994-01       Impact factor: 0.142

6.  Sera from women with unexplained infertility inhibit both mouse and human embryo growth in vitro.

Authors:  A Dokras; I L Sargent; C W Redman; D H Barlow
Journal:  Fertil Steril       Date:  1993-08       Impact factor: 7.329

7.  Optimization and simplification of culture conditions in human in vitro fertilization (IVF) and preembryo replacement by serum-free media.

Authors:  N Holst; K Bertheussen; F Forsdahl; M B Håkonsen; L J Hansen; H I Nielsen
Journal:  J In Vitro Fert Embryo Transf       Date:  1990-02

8.  Serum is not necessary in human in vitro fertilization, early embryo culture, and transfer.

Authors:  Y Menezo; J Testart; D Perrone
Journal:  Fertil Steril       Date:  1984-11       Impact factor: 7.329

9.  High continuing pregnancy rates after in vitro fertilization-embryo transfer using medium supplemented with a plasma protein fraction containing alpha- and beta-globulins.

Authors:  T B Pool; J E Martin
Journal:  Fertil Steril       Date:  1994-04       Impact factor: 7.329

10.  Effects of human serum and plasma on development of mouse embryos in culture media.

Authors:  B Shirley; J W Wortham; J Witmyer; M Condon-Mahony; G Fort
Journal:  Fertil Steril       Date:  1985-01       Impact factor: 7.329

  10 in total
  5 in total

1.  Globulins in protein supplements promote the development of preimplantation embryos.

Authors:  M Tanikawa; T Harada; M Ito; S Yoshida; T Iwabe; N Terakawa
Journal:  J Assist Reprod Genet       Date:  1999-11       Impact factor: 3.412

2.  Development of a well-defined medium for the in vitro maturation of immature bovine cumulus-oocyte complexes.

Authors:  A Chanson; D Nocera; A Senn; P De Grandi; M Germond
Journal:  J Assist Reprod Genet       Date:  2001-02       Impact factor: 3.412

3.  A simple method of culture of 11.5-day-old rat embryos in DMEM/F12 and 20% fetal bovine serum.

Authors:  A Ornoy; S Yacobi; P Yaffee
Journal:  J Anat       Date:  2003-10       Impact factor: 2.610

4.  Longevity of donor serum.

Authors:  Jennifer E Graves; H Lee Higdon; Jane E Johnson; Dawn W Blackhurst; William R Boone
Journal:  J Assist Reprod Genet       Date:  2004-02       Impact factor: 3.412

5.  Application of two different synthetic sequential media for the human IVF-ET program: a prospective, randomized, and comparative study.

Authors:  Jeong Yoon; Hye-Jin Yoon; Kyoung-Mi Juhn; Jin-Kyung Ko; San-Hyun Yoon; Yong Ko; Jin-Ho Lim
Journal:  Clin Exp Reprod Med       Date:  2011-12-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.